BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19724988)

  • 1. Nuclear medicine imaging of the pediatric musculoskeletal system.
    Shammas A
    Semin Musculoskelet Radiol; 2009 Sep; 13(3):159-80. PubMed ID: 19724988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear Medicine Applications in Pediatric Musculoskeletal Diseases: The Added Value of Hybrid Imaging.
    Parisi MT; Iyer RS; Stanescu AL
    Semin Musculoskelet Radiol; 2018 Feb; 22(1):25-45. PubMed ID: 29409071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Miscellaneous cancers (lung, thyroid, renal cancer, myeloma, and neuroendocrine tumors): role of SPECT and PET in imaging bone metastases.
    Chua S; Gnanasegaran G; Cook GJ
    Semin Nucl Med; 2009 Nov; 39(6):416-30. PubMed ID: 19801221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET/CT in musculoskeletal infection.
    Strobel K; Stumpe KD
    Semin Musculoskelet Radiol; 2007 Dec; 11(4):353-64. PubMed ID: 18324599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pictorial review of
    Ishibashi M; Tanabe Y; Fujii S; Ogawa T
    Ann Nucl Med; 2017 Jul; 31(6):437-453. PubMed ID: 28585058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the clinical diagnosis of lung cancer].
    Demura Y; Mizuno S; Wakabayashi M; Totani Y; Okamura S; Ameshima S; Ishizaki T; Miyamori I; Ito H; Yonekura Y
    Nihon Kokyuki Gakkai Zasshi; 2000 Sep; 38(9):676-81. PubMed ID: 11109804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical efficacy of (18)F-FDG-PET/CT in benign and malignant musculoskeletal tumors.
    Shin DS; Shon OJ; Han DS; Choi JH; Chun KA; Cho IH
    Ann Nucl Med; 2008 Aug; 22(7):603-9. PubMed ID: 18756363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolution of nuclear medicine and the musculoskeletal system.
    Palestro CJ; Love C; Schneider R
    Radiol Clin North Am; 2009 May; 47(3):505-32. PubMed ID: 19361673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of PET in the evaluation of musculoskeletal infections.
    Rowe SP; Cho SY
    Semin Musculoskelet Radiol; 2014 Apr; 18(2):166-74. PubMed ID: 24715448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer: role of SPECT and PET in imaging bone metastases.
    Ben-Haim S; Israel O
    Semin Nucl Med; 2009 Nov; 39(6):408-15. PubMed ID: 19801220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of FDG single-photon emission computed tomography: Computed tomography in the diagnosis of head and neck cancers and study of its mechanism.
    Li LF; Zhou SH; Zhao K; Wang SQ; Wu QL; Fan J; Cheng KJ; Ling L
    Cancer Biother Radiopharm; 2008 Dec; 23(6):701-14. PubMed ID: 19317609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U; Even-Sapir E
    Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET and PET/CT in pediatric oncology.
    Jadvar H; Connolly LP; Fahey FH; Shulkin BL
    Semin Nucl Med; 2007 Sep; 37(5):316-31. PubMed ID: 17707239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of (18)F-FDG-PET/CT with (99m)Tc-MDP bone scintigraphy for the detection of bone metastases in cancer patients.
    Ozülker T; Küçüköz Uzun A; Ozülker F; Ozpaçac T
    Nucl Med Commun; 2010 Jun; 31(6):597-603. PubMed ID: 20224457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone scan update.
    Nadel HR
    Semin Nucl Med; 2007 Sep; 37(5):332-9. PubMed ID: 17707240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordant findings of skeletal metastasis between tc 99M MDP bone scans and F18 FDG PET/CT imaging for advanced breast and lung cancers--two case reports and literature review.
    Chen YW; Huang MY; Hsieh JS; Hou MF; Chou SH; Lin CL
    Kaohsiung J Med Sci; 2007 Dec; 23(12):639-46. PubMed ID: 18192101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease.
    Horger M; Bares R
    Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
    Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.